Efficacy of anti-SARS-CoV-2 mRNA vaccine in systemic autoimmune disorders: induction of high avidity and neutralising anti-RBD antibodies.

Chiara Tani Federico Pratesi Rosaria TalaricoChiara CardelliTeresita CarusoFederica Di CianniElenia LaurinoNazzareno ItalianoMichele MorettiMaria Laura MancaPaola MiglioriniMarta Mosca

Published in: RMD open (2021)

These data show that double-dose vaccination induced in patients with SARDs anti-RBD IgG and IgA antibodies in amounts not significantly different from controls, and, most interestingly, characterised by high avidity and endowed with neutralising activity.

Keyphrases

sars cov
drug induced
multiple sclerosis
diabetic rats
oxidative stress
respiratory syndrome coronavirus
deep learning